A Study to Establish Safety and Maximum Tolerated Dose of IV Trehalose in Healthy Subjects

Clinical trial NCT02725957 · COMPLETED

Trial details

NCT number: NCT02725957
Sponsor: Bioblast Pharma Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Subjects

Start date: 2016-03-01
Primary completion: 2016-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.